<DOC>
	<DOC>NCT02040025</DOC>
	<brief_summary>The purpose of this proposed Department of Defense study is to evaluate the effect of Enhanced External Counterpulsation (EECP) on circulation, blood glucose control and blood pressure of type 2 diabetic patients receiving EECP therapy.</brief_summary>
	<brief_title>Evaluating the Effects of EECP on Circulation, Blood Glucose Level and Blood Pressure in Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<criteria>1. Age equal to or greater than 18. 2. Type 2 diabetes mellitus. 3. Enrollment in the Travis AFB, CA EECP Clinic. 4. Department of Defense Beneficiary.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>hypertension</keyword>
	<keyword>diabetes mellitus</keyword>
	<keyword>hemoglobin A1C</keyword>
	<keyword>peripheral vascular resistance</keyword>
	<keyword>EECP</keyword>
	<keyword>Blood pressure</keyword>
	<keyword>angiogenesis</keyword>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>Coronary Disease</keyword>
	<keyword>Heart Diseases</keyword>
	<keyword>Cardiovascular Diseases</keyword>
</DOC>